| 10174061 |
Carbidopa and L-dopa prodrugs and methods of use |
Benoit Cardinal-David, Vincent S. Chan, Brian P. Enright, Ye Huang, Alexander D. Huters +13 more |
2019-01-08 |
$448,358,000 |
| 10039754 |
Anti-viral compounds |
Mary E. Bellizzi, David A. Betebenner, Jean C. Califano, William A. Carroll, Daniel D. Caspi +24 more |
2018-08-07 |
$510,993,000 |
| 10028937 |
Anti-viral compounds |
Mary E. Bellizzi, David A. Betebenner, Jean C. Califano, William A. Carroll, Daniel D. Caspi +24 more |
2018-07-24 |
$1,044,607,000 |
| 9969693 |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use |
Andrew Bogdan, Marlon D. Cowart, David A. DeGoey, Tammie K. Jinkerson, John R. Koenig +7 more |
2018-05-15 |
$1,082,127,000 |
| 9783527 |
Indazole ureas and method of use |
Jerome F. Daanen, David A. DeGoey, Jennifer M. Frost, John R. Koenig, Steve Latshaw +3 more |
2017-10-10 |
$702,755,000 |
| 9586978 |
Anti-viral compounds |
Mary E. Bellizzi, David A. Betebenner, Jean C. Califano, William A. Carroll, Daniel D. Caspi +24 more |
2017-03-07 |
$167,877,000 |
| 9452986 |
6-heteroaryloxy- or 6-aryloxy-quinoline-2-carboxamides and method of use |
Andrew Bogdan, Marlon D. Cowart, David A. DeGoey, Tammie K. Jinkerson, John R. Koenig +7 more |
2016-09-27 |
$228,077,000 |
| 9446059 |
Carbidopa and L-dopa prodrugs and methods of use |
Benoit Cardinal-David, Vincent S. Chan, Kassibla E. Dempah, Brian P. Enright, Rodger F. Henry +16 more |
2016-09-20 |
$181,373,000 |
| 9278922 |
Anti-viral compounds |
Pamela L. Donner, Lissa T. Nelson, Tammie K. Jinkerson, Ryan G. Keddy, Christopher E. Motter +7 more |
2016-03-08 |
$315,551,000 |
| 9163017 |
Anti-viral compounds |
David A. DeGoey, Pamela L. Donner, Warren M. Kati, Charles W. Hutchins, Tammie K. Jinkerson +1 more |
2015-10-20 |
$87,093,000 |
| 9012651 |
TRPV3 modulators |
Bruce Clapham, Phil B. Cox, Michael J. Dart, Arthur Gomtsyan, Tammie K. Jinkerson +7 more |
2015-04-21 |
$538,936,000 |
| 9006387 |
Anti-viral compounds |
Rolf Wagner, John K. Pratt, Dachun Liu, Michael D. Tufano, David A. DeGoey +23 more |
2015-04-14 |
$88,919,000 |
| 8937150 |
Anti-viral compounds |
David A. DeGoey, Warren M. Kati, Charles W. Hutchins, Pamela L. Donner, Allan C. Krueger +24 more |
2015-01-20 |
$146,470,000 |
| 8921514 |
Anti-viral compounds |
David A. DeGoey, Warren M. Kati, Charles W. Hutchins, Pamela L. Donner, Allan C. Krueger +24 more |
2014-12-30 |
$164,094,000 |
| 8691938 |
Anti-viral compounds |
David A. DeGoey, Warren M. Kati, Charles W. Hutchins, Pamela L. Donner, Allan C. Krueger +23 more |
2014-04-08 |
$56,269,000 |
| 8541424 |
Anti-viral compounds |
David A. DeGoey, Pamela L. Donner, Warren M. Kati, Charles W. Hutchins, Tammie K. Jinkerson +1 more |
2013-09-24 |
$23,299,000 |
| 7998982 |
Amide derivatives as TRPV1 antagonists |
Anil Vasudevan, Brian S. Brown, Jerome F. Daanen, Arthur Gomtsyan, Tammie K. Jinkerson +3 more |
2011-08-16 |
$18,160,000 |
| 7528134 |
Acetamides and benzamides that are useful in treating sexual dysfunction |
Pramila Bhatia, Jerome F. Daanen, Ahmed Hakeem, Teodozyj Kolasa, Kathleen H. Mortell +5 more |
2009-05-05 |
$152,385,000 |
